Variations in white blood count, thromboxane B2 levels and hematocrit in chronic venous hypertension

Sao Paulo Med J. 1998 May-Jun;116(3):1721-6. doi: 10.1590/s1516-31801998000300006.

Abstract

Objective: To analyze variations in leukocyte count and thromboxane B2 production in the femoral vein of patients with chronic venous hypertension (CVH).

Design: Prospective clinical study, controlled, non randomized and open.

Location: Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, referral center, university hospital.

Participants: 15 patients with recurring stasis ulcer were analyzed, selected randomly from the venous diseases outpatient center, and 4 without lower limb venous alterations were also analyzed.

Intervention: Blood samples from the femoral and brachial veins were drawn following supine and 45 degrees reverse Trendelenburg.

Main outcomes measures: Direct leukocyte count and analysis of the thromboxane B2 with enzyme linked immunosorbent assay test.

Results: After 30 minutes in reverse Trendelenburg, patients with CVH showed a leukocyte count reduced by +/- 27% (p = 0.02) and thromboxane B2 levels increased by +/- 158% (p = 0.02).

Conclusions: We suggest that future studies of medications for stasis ulcers include their effects on leukocyte entrapment and thromboxane B2 production in the lower limb venous system.

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Female
  • Hematocrit*
  • Humans
  • Leukocyte Count*
  • Male
  • Middle Aged
  • Prospective Studies
  • Thromboxane B2 / blood*
  • Thromboxane B2 / metabolism
  • Varicose Ulcer / blood*
  • Varicose Ulcer / metabolism

Substances

  • Thromboxane B2